Kinled

Type of investor
VC
Based in
Vienna
Number of investments
6-10
Industry
biotech, medtech

Visit website of
Kinled

Related News

10.02.2023 15:40

ETH medtech spinoff secures USD 12 million

Financing

04.10.2022 09:10

CHF1.3 million to bring precision medicine to all cancer patients

Financing

27.04.2021 16:40

PreComb Therapeutics secures CHF 2.2 Mio seed financing

Financing

17.12.2019 10:17

Aleva secures a CE mark and $8 million

Financing

Success

04.10.2017 08:30

Aleva Neurotherapeutics raises USD 13 Million in Series D round

Financing

25.10.2016 10:15

KB Medical SA Raises CHF 2.5 Million in Series B

Financing

Name
Kinled

Principal

Innosuisse

Swiss Venture Capital Report

Swiss Venture Capital Report

The new Swiss Venture Capital Report provides a review of the whole of 2023. In addition to investments, the report will once again include the results of a survey of Swiss investors, an overview of venture capital fundraising and a list of exits. You can download the Report in our asset section.

Register for more services

Partners

Gebert Rüf Stiftung

Swiss Entrepreneurs Foundation

UBS

Contributors

EPFL Innovation Park Foundation

IFJ

Innovaud

Kendris

Lichtsteiner Foundation

SICTIC

Startup Campus

Startup Days

Swiss Economic Forum

Swisscom

Swissnex

Switzerland Innovation

venturelab

W.A. De Vigier Stiftung

Supporters

Basel Area Business & Innovation

Business Angels Switzerland

ESA BIC Switzerland

StartAngels Network

Switzerland Global Enterprise

Technology Fund

Technopark Luzern

Technopark Winterthur

TECHNOPARK Zürich

University of Basel

USI Startup Centre

Supporters

Basel Area Business & Innovation

Business Angels Switzerland

EPFL Innovation Park Foundation

ESA BIC Switzerland

Gebert Rüf Stiftung

StartAngels Network

Swiss Entrepreneurs Foundation

Switzerland Global Enterprise

Switzerland Innovation

Technology Fund

Technopark Luzern

Technopark Winterthur

TECHNOPARK Zürich

University of Basel

USI Startup Centre

W.A. De Vigier Stiftung

By continuing to use this website you agree with our TERMS AND CONDITIONS